The company
Omnicell, Inc.
OMCL · Nasdaq
OMCL stood above a rising 150-day average in 26 of the last 52 weekly readings, and has been out of that trend for the last 13 weeks. It is 7.4% below that average now. Medical Devices: 27% of its 181 stocks in an uptrend (−9 points in four weeks); Health Care: 25% (−11 points in four weeks).
Statistics
- Rotation
- Not moving yet
- Weeks in an uptrend
- out for 13
- Industry in uptrend
- 27% -9 in 4 wk
- Insider buys, 12 months
- $0
- Insider sales, 12 months
- $4.7M
- Officials’ trades on record
- 12
In the rotation
Each square a week: lit when it closed above a rising 150-day average. 26 of 52 weeks.
Medical Devices: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks. Health Care: A minority of its stocks are in an uptrend and the share has fallen sharply over four weeks.
Money in and out
Open-market buys above the line and sales below, in dollars. Not yet read: institutions.
Congress and officials
12 disclosed lines: House 10, Senate 1, executive 1; 4 people.
| Who | Did | Amount | Traded |
|---|---|---|---|
| Donald J. Trump Executive branch: Office of Government EthicsWhite House Office | sold | $15k–$50k | 29 Jul 2026filed 22 Sep 2026 |
| Sara Jacobs House: U.S. House ClerkCA53 | sold | $50k–$100k | 9 Apr 2021filed 28 May 2021 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $1k–$15k | 19 Dec 2017filed 2 Jan 2018 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $1k–$15k | 9 Dec 2015filed 21 Dec 2015 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $1k–$15k | 30 Oct 2015filed 13 Nov 2015 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $1k–$15k | 11 May 2015filed 22 May 2015 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $1k–$15k | 8 May 2015filed 22 May 2015 |
| James B. Renacci House: U.S. House ClerkOH16 | sold | $1k–$15k | 11 Mar 2015filed 18 Mar 2015 |
| Thom Tillis Senate: U.S. Senate eFDSenator | soldjoint | $1k–$15k | 13 Feb 2015filed 26 Feb 2015 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $1k–$15k | 30 Oct 2014filed 10 Nov 2014 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $1k–$15k | 15 Aug 2014filed 22 Aug 2014 |
| James B. Renacci House: U.S. House ClerkOH16 | bought | $1k–$15k | 31 Jul 2014filed 6 Aug 2014 |
Insiders
| Who | Did | Shares | Traded |
|---|---|---|---|
| Nnamdi NjokuPresident & COO | sold | 3,083at $36.85 | 17 Aug 2026filed 18 Aug 2026 |
| Randall A. LippsCHAIRMAN, CEO | sold | 10,000at $47.00 | 15 Jul 2026filed 17 Jul 2026 |
| Corey J. ManleyEVP&CHIEF LEGAL/ADMIN OFFICER | sold | 5,025at $43.22 | 18 May 2026filed 19 May 2026 |
| Nnamdi NjokuEVP, Chief Operating Officer | sold | 3,090at $43.22 | 18 May 2026filed 19 May 2026 |
| Corey J. ManleyEVP&CHIEF LEGAL/ADMIN OFFICER | sold | 7,405at $34.69 | 16 Mar 2026filed 17 Mar 2026 |
| Corey J. ManleyEVP&CHIEF LEGAL/ADMIN OFFICER | sold | 4,243at $36.59 | 17 Feb 2026filed 18 Feb 2026 |
| Corey J. ManleyEVP&CHIEF LEGAL/ADMIN OFFICER | sold | 6,106at $49.90 | 8 Jan 2026filed 12 Jan 2026 |
Lines filed since 2 January 2026, newest first; every insider’s older lines are on their own page.
Institutions
Still reading this part; it fills in a moment.
News
No headline names it lately.
Everyone who traded it
Same industry
Government contracts
From its SEC filings
Analyst forecasts
No analyst forecasts yet.